France opens investigation into chemotherapy drug Taxotere following the deaths of 5 women

March 10, 2017 – San Diego, CA — French regulators are investigating the deaths of 5 women who took the chemotherapy drug docetaxel to treat breast cancer. Docetaxel is the generic...

New trial schedule sees first Xarelto bellwether starting in April

March 9, 2017 – San Diego, CA — Plaintiffs and defendants are gearing up for the first bellwether trial in the Xarelto multidistrict litigation (MDL) set to begin next month. The...

Xarelto sales increase along with lawsuits

March 8, 2017 – San Diego, CA -- 2016 was a big year for Johnson & Johnson’s oral anticoagulant Xarelto. The blockbuster drug brought in more than $2.2 billion in...

Risperdal gynecomastia lawsuit tossed by judge a week before trial

March 7, 2017 – San Diego, CA — A Risperdal gynecomastia lawsuit slated for trial Monday was tossed by the presiding judge last week. It would have been the seventh case...

3 things you need to know about Xarelto and alcohol use

Xarelto hit the market in 2011 and has since become one of the best-selling blood thinners on the market. Last year, the drug brought in more than $2.2 billion for...

Product in Place lawsuits an option for IVC filter patients with no complications

Do you have a retrievable IVC filter implanted but haven’t suffered any known complications? You may still be able to file a claim. March 3, 2017 – San Diego, CA...

Failed hernia meshes hurt patients physically and financially

March 2, 2017 – San Diego, CA — Hernia repair surgeries are incredibly common in the United States and more and more surgeons are choosing to use surgical mesh to...

New Case Study: IVC filter complications can happen decades later

March 1, 2017 – San Diego, CA — A new case study shows IVC filter complications can occur many years after implantation and reminds doctors to remove filters as early...

18,500 Risperdal cases and counting – J&J releases total lawsuit numbers in new annual report

Feb. 28, 2017 – San Diego, CA — 18,500. That’s how many Risperdal lawsuits are pending nationwide against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, according to J&J’s new...

Attorneys call out Janssen’s move to require documentation of Risperdal injuries on new plaintiff fact sheets

Feb. 27, 2017 – San Diego, CA — Attorneys for plaintiffs in Philadelphia’s Risperdal litigation are pushing back against a call by Janssen Pharmaceuticals to require more medical documentation on...